Skip to content

Clinical Validation of the Norbert Health Device for Pulse Rate Measurement

Clinical Validation of the Norbert Health Device for Pulse Rate Measurement

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06874504
Enrollment
40
Registered
2025-03-13
Start date
2025-03-13
Completion date
2025-04-11
Last updated
2025-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The study will evaluate the measuring pulse rate (PR) using the Norbert Device (ND) as compared to a reference heart rate measured using an electrocardiogram (ECG).

Detailed description

The study design is to validate the pulse rate accuracy. The study is a non-randomized, non-blinded single arm design to evaluate the clinical accuracy of the ND's pulse rate measurement compared to a reference heart rate manually measured by observing R-peaks in a standard concurrently recorded ECG from an FDA 510(k)-cleared reference clinical ECG (RCECG). The sponsor will ensure that the study staff enrolls a range of subjects.

Interventions

The Norbert Device (ND) is a contactless, noninvasive device that provides measurements of pulse rate.

Sponsors

Integrative Clinical Trials, LLC
CollaboratorUNKNOWN
Norbert Health
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects must be 18 years or older * Ability to comprehend written consent and provide informed consent * Ability to commit to and complete study related paperwork and activities (i.e. subject forms, have de-identified pictures taken, comply with periods of no movement, etc.)

Exclusion criteria

* Pregnant women * Diagnosis of essential tremor or any medical condition causing tremors of the head or hands * Facial tattoos, scars, large moles, beards/hair growth, birthmarks, vitiligo, skin conditions, facial discoloration, or heavy makeup within the areas of interest * Inability for subject to avoid extreme movement during measurement reading windows * Inability for subject to raise their hand during measurement reading windows * No heart arrythmias * Discretion of the Principal investigator or clinical study staff

Design outcomes

Primary

MeasureTime frameDescription
Primary ObjectiveApproximately 1 hourTo validate the accuracy specification for pulse rate from the ND when compared to an FDA-cleared medical device for heart rate monitoring electrocardiogram (ECG monitor, 5 lead).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026